Seth E. Cockrum

Seth E. Cockrum

ID: 1b83c153-2619-30fb-68c4

/

Claimed Record

/

Organization: Rothwell Figg

Pfizer Files Another IPR Against Genentech’s ʼ441 Patent

Biosimilars Law Bulletin · October 4, 2017

Sanofi, Genzyme, and Regeneron Voluntarily Dismiss Dupixent® (Dupilumab) Declaratory Judgment Suit in Massachusetts

Biosimilars Law Bulletin · May 8, 2017

Immunex Files Patent Infringement Suit Over Dupixent® (Dupilumab) and Seeks to Dismiss or Transfer Sanofi and Regeneron’s Prior DJ Complaint

Biosimilars Law Bulletin · April 12, 2017

Sanofi and Regeneron Follow Declaratory Judgment Complaint with an IPR Petition as FDA Approves Dupixent® (dupilumab)

Biosimilars Law Bulletin · March 30, 2017

Sanofi and Regeneron Seek Declaratory Judgment that Dupixent® (Dupilumab) Does Not Infringe Amgen’s Patent

Biosimilars Law Bulletin · March 22, 2017

Practice Areas

Health Care and Life Sciences

Jurisdictions

Washington, D.C.